++
++
Two classic features of Wolff-Parkinson-White (WPW) pattern on ECG
Most patients with WPW pattern do not have clinical history of arrhythmia but have a higher risk of sudden cardiac death due to rapidly conducted atrial fibrillation through the accessory pathway
Risk factors
++
Accessory pathways occur in 0.1–0.3% of the population and facilitate reentrant arrhythmias
Orthodromic reentrant tachycardia
Accounts for ~ 90% of atrioventricular reciprocating tachycardia (AVRT) episodes
Characterized by conduction antegrade down the AV node and retrograde up the accessory pathway, resulting in a narrow QRS complex (unless an underlying bundle branch block or interventricular conduction delay is present)
Antidromic reentrant tachycardia
Atrial fibrillation or flutter with antegrade conduction down the accessory pathway and a rapid ventricular response seen in up to 30% of patients with Wolff-Parkinson-White syndrome
++
Some patients have a delta wave found incidentally on ECG
Exercise treadmill testing useful in determining if preexcitation is lost at rapid rates
Electrophysiologic testing with possible catheter ablation useful to ensure patients are not at an increased risk for syncope or sudden death
Patients found to have the shortest preexcited R-R interval (SPERRI) during atrial fibrillation of ≤ 250 msec or inducible supraventricular tachycardia are at increased risk for sudden cardiac death
Should undergo catheter ablation
++
For narrow-complex reentrant rhythms involving a bypass tract (orthodromic AVRT)
Vagal maneuvers
Intravenous adenosine
Intravenous verapamil
For wide-complex tachycardia in the presence of an accessory pathway, be it reentrant-type (antidromic AVRT) or atrial fibrillation with antegrade conduction down the bypass tract
Intravenous class Ia (procainamide) and class III (ibutilide) antiarrhythmic agents
If hemodynamic compromise is present, electrical cardioversion is warranted
Agents such as calcium channel blockers and beta-blockers should be avoided because of increased risk of ventricular fibrillation
Agents such as calcium channel blockers, and β-blockers should be avoided
Amiodarone can be effective in refractory cases
If hemodynamic compromise is present, electrical cardioversion is warranted
Radiofrequency ablation is the procedure of choice for long-term management of patients with accessory pathways and recurrent symptoms
For patients not a candidate for catheter ablation, class Ic or class III antiarrhythmic medication may be considered